Importantly, CXCR2 blockade at 8 weeks of age in NOD mice was sufficient to significantly reduce the presence of islet autoreactive CD8+ T cells and led to a reduction in the prevalence of T1D in mice up to 40 weeks of age (3). The gene discussed is CXCR2; the disease is type 1 diabetes mellitus.